Value of Serum Retinol-Binding Protein, Lipoprotein A and Inflammatory Nutritional Indexes and their Interactions in Predicting Acute Kidney Injury after Coronary Angiography
DOI:
https://doi.org/10.59958/hsf.7985Keywords:
contrast-induced acute kidney injury, coronary angiography, retinol-binding protein, lipoprotein A, interleukin-6, nutritional markersAbstract
Background: Contrast-induced acute kidney injury (CI-AKI) is a serious condition that can arise after undergoing coronary angiography (CAG). This complication is primarily caused by the toxic impact of contrast agents on the kidneys, along with oxidative stress and inflammatory responses. Identifying reliable biomarkers for early prediction remains essential due to the limited accuracy of existing clinical risk scores. Methods: This retrospective case-control study included 365 patients undergoing CAG between December 2021 and December 2023. Patients were categorized into non-AKI (n = 320) and AKI (n = 45) groups based on post-procedural renal function. Biomarkers including serum retinol-binding protein (RBP), lipoprotein A (Lp(a)), interleukin-6 (IL-6), and nutritional markers were measured. Baseline demographics, lipid profiles, and procedure details were recorded. Results: Baseline characteristics revealed no significant differences between groups in terms of age, BMI, gender, and prevalence of hypertension or diabetes mellitus. Notably, RBP (41.83 ± 10.22 mg/L vs. 32.45 ± 8.76 mg/L, p < 0.001), Lp(a) (42.35 ± 13.87 mg/dL vs. 35.76 ± 11.54 mg/dL, p < 0.001), and IL-6 (6.23 ± 2.14 pg/mL vs. 4.87 ± 1.59 pg/mL, p < 0.001) levels were significantly higher in the AKI group. Total protein levels were significantly lower in the AKI group (6.88 ± 0.62 g/dL vs. 7.12 ± 0.54 g/dL, p = 0.006). Multivariate logistic regression identified RBP (OR 1.118, 95% CI 1.072–1.166, p < 0.001), Lp(a) (OR 1.047, 95% CI 1.014–1.080, p = 0.005), and IL-6 (OR 1.710, 95% CI 1.355–2.157, p < 0.001) as independent predictors of AKI, while higher total protein levels were protective (OR 0.497, 95% CI 0.257–0.960, p = 0.037). Conclusion: Serum RBP, Lp(a), IL-6, and total protein levels are valuable biomarkers for predicting CI-AKI after CAG. Elevated RBP, Lp(a), and IL-6 indicate higher risk, while higher total protein suggests protective effects.
References
Cheng AS, Li X. The Potential Biotherapeutic Targets of Contrast-Induced Acute Kidney Injury. International Journal of Molecular Sciences. 2023; 24: 8254. https://doi.org/10.3390/ijms24098254
Lin Q, Li S, Jiang N, Shao X, Zhang M, Jin H, et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation. Redox Biology. 2019; 26: 101254. https://doi.org/10.1016/j.redox.2019.101254
Ramachandran P, Jayakumar D. Contrast-induced Acute Kidney Injury. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine. 2020; 24: S122–S125. https://doi.org/10.5005/jp-journals-10071-23379
Azzalini L, Kalra S. Contrast-Induced Acute Kidney Injury-Definitions, Epidemiology, and Implications. Interventional Cardiology Clinics. 2020; 9: 299–309. https://doi.org/10.1016/j.iccl.2020.02.001
Chandiramani R, Cao D, Nicolas J, Mehran R. Contrast-induced acute kidney injury. Cardiovascular Intervention and Therapeutics. 2020; 35: 209–217. https://doi.org/10.1007/s12928-020-00660-8
Morcos R, Kucharik M, Bansal P, Al Taii H, Manam R, Casale J, et al. Contrast-Induced Acute Kidney Injury: Review and Practical Update. Clinical Medicine Insights. Cardiology. 2019; 13: 1179546819878680. https://doi.org/10.1177/1179546819878680
Chaudhari H, Mahendrakar S, Baskin SE, Reddi AS. Contrast-Induced Acute Kidney Injury: Evidence in Support of Its Existence and a Review of Its Pathogenesis and Management. International Journal of Nephrology and Renovascular Disease. 2022; 15: 253–266. https://doi.org/10.2147/ijnrd.s371700
Sůva M, Kala P, Poloczek M, Kaňovský J, Štípal R, Radvan M, et al. Contrast-induced acute kidney injury and its contemporary prevention. Frontiers in Cardiovascular Medicine. 2022; 9: 1073072. https://doi.org/10.3389/fcvm.2022.1073072
D'Amore C, Nuzzo S, Briguori C. Biomarkers of Contrast-Induced Nephropathy:: Which Ones are Clinically Important? Interventional Cardiology Clinics. 2020; 9: 335–344. https://doi.org/10.1016/j.iccl.2020.02.004
Li Y, Ma K, Shen G, Zheng D, Xuan Y, Li W. Impact of small and dense low-density lipoprotein (sd-LDL)on contrast-induced acute kidney injury in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. International Urology and Nephrology. 2021; 53: 2611–2617. https://doi.org/10.1007/s11255-021-02821-x
Fu Y, Cao J, Wei X, Ge Y, Su Z, Yu D. Klotho alleviates contrast-induced acute kidney injury by suppressing oxidative stress, inflammation, and NF-KappaB/NLRP3-mediated pyroptosis. International Immunopharmacology. 2023; 118: 110105. https://doi.org/10.1016/j.intimp.2023.110105
Deng YH, Wang XF, Wu X, Yan P, Liu Q, Wu T, et al. Differential renal proteomics analysis in a novel rat model of iodinated contrast-induced acute kidney injury. Renal failure. 2023; 45: 2178821. https://doi.org/10.1080/0886022X.2023.2178821
Jana S, Mitra P, Roy S. Proficient novel biomarkers guide early detection of acute kidney injury: a review. Diseases. 2022; 11: 8. https://doi.org/10.3390/diseases11010008
Schiborn C, Weber D, Grune T, Biemann R, Jäger S, Neu N, et al. Retinol and Retinol Binding Protein 4 Levels and Cardiometabolic Disease Risk. Circulation Research. 2022; 131: 637–649. https://doi.org/10.1161/CIRCRESAHA.122.321295
Barbagelata L, Masson W, Corral P, Lavalle-Cobo A, Nogueira JP, Rosa Diez G. Relationship between lipoprotein(a) levels, cardiovascular outcomes and death in patients with chronic kidney disease: a systematic review of prospective studies. Journal of Nephrology. 2023; 36: 1549–1559. https://doi.org/10.1007/s40620-023-01590-3
Wang A, Zhang S, Li Y, Zhu F, Xie B. Study on the relationship between lipoprotein (a) and diabetic kidney disease. Journal of Diabetes and its Complications. 2023; 37: 108378. https://doi.org/10.1016/j.jdiacomp.2022.108378
Doberer K, Duerr M, Halloran PF, Eskandary F, Budde K, Regele H, et al. A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection. Journal of the American Society of Nephrology: JASN. 2021; 32: 708–722. https://doi.org/10.1681/asn.2020071106
Tanaka K, Harada H, Kamuro H, Sakai H, Yamamoto A, Tomimatsu M, et al. Arid5a/IL-6/PAI-1 Signaling Is Involved in the Pathogenesis of Lipopolysaccharide-Induced Kidney Injury. Biological & Pharmaceutical Bulletin. 2023; 46: 1753–1760. https://doi.org/10.1248/bpb.b23-00482
Wang Z, Shen J, Ye K, Zhao J, Huang S, He S, et al. Neutrophil-Derived IL-6 Potentially Drives Ferroptosis Resistance in B Cells in Lupus Kidney. Mediators of Inflammation. 2023; 2023: 9810733. https://doi.org/10.1155/2023/9810733
Abellás-Sequeiros RA, Raposeiras-Roubín S, Abu-Assi E, González-Salvado V, Iglesias-Álvarez D, Redondo-Diéguez A, et al. Mehran contrast nephropathy risk score: Is it still useful 10 years later? Journal of Cardiology. 2016; 67: 262–267. https://doi.org/10.1016/j.jjcc.2015.05.007
Rezk T, Salota R, Gan JJ, Lachmann HJ, Fontana M, Siew K, et al. Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis. British Journal of Haematology. 2021; 194: 1016–1023. https://doi.org/10.1111/bjh.17706
Su Y, Huang Y, Jiang Y, Zhu M. The Association between Serum Retinol-Binding Protein 4 Levels and Cardiovascular Events in Patients with Chronic Kidney Disease. Laboratory Medicine. 2020; 51: 491–497. https://doi.org/10.1093/labmed/lmz104
Abbasi F, Moosaie F, Khaloo P, Dehghani Firouzabadi F, Fatemi Abhari SM, Atainia B, et al. Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease. Kidney & Blood Pressure Research. 2020; 45: 222–232. https://doi.org/10.1159/000505155
Zhou XH, Liu SY, Yang B, Li YF, Hou BH. Urinary orosomucoid and retinol binding protein levels as early diagnostic markers for diabetic kidney Disease. BMC Nephrology. 2023; 24: 357. https://doi.org/10.1186/s12882-023-03363-3
Kwiatkowska E, Kwiatkowski S, Dziedziejko V, Tomasiewicz I, Domański L. Renal microcirculation injury as the main cause of ischemic acute kidney injury development. Biology (Basel). 2023; 12: 327. https://doi.org/10.3390/biology12020327
Liu Y, Wang R, Li S, Zhang C, Lip GYH, Thabane L, et al. Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study. JMIR Public Health and Surveillance. 2024; 10: e50415. https://doi.org/10.2196/50415
Friedmann J, Schuster A, Reichelt-Wurm S, Banas B, Bergler T, Steines L. Serum IL-6 predicts risk of kidney transplant failure independently of immunological risk. Transplant Immunology. 2024; 84: 102043. https://doi.org/10.1016/j.trim.2024.102043
Guo X, Zhu Y, Sun Y, Li X. IL-6 accelerates renal fibrosis after acute kidney injury via DNMT1-dependent FOXO3a methylation and activation of Wnt/β-catenin pathway. International Immunopharmacology. 2022; 109: 108746. https://doi.org/10.1016/j.intimp.2022.108746
Wang J, Xiong M, Fan Y, Liu C, Wang Q, Yang D, et al. Mecp2 protects kidney from ischemia-reperfusion injury through transcriptional repressing IL-6/STAT3 signaling. Theranostics. 2022; 12: 3896–3910. https://doi.org/10.7150/thno.72515
Zhu H, Chu W, Han S, Gao B, Wang X. Urinary proteomics investigations into contrast-induced acute kidney injury. PloS One. 2021; 16: e0258736. https://doi.org/10.1371/journal.pone.0258736
Groza Y, Jemelkova J, Kafkova LR, Maly P, Raska M. IL-6 and its role in IgA nephropathy development. Cytokine & Growth Factor Reviews. 2022; 66: 1–14. https://doi.org/10.1016/j.cytogfr.2022.04.001
Jeon HJ, Shin DH, Oh J, Kee YK, Park JY, Ko K, et al. Urinary Retinol-Binding Protein 4 is Associated With Renal Function and Rapid Renal Function Decline in Kidney Transplant Recipients. Transplantation Proceedings. 2022; 54: 362–366. https://doi.org/10.1016/j.transproceed.2021.10.028
Connolly CM, Li J, Goldman D, Fava A, Magder L, Petri M. Lipoprotein(a) in systemic lupus erythematosus is associated with history of proteinuria and reduced renal function. Lupus. 2022; 31: 1367–1372. https://doi.org/10.1177/09612033221111958
Published
How to Cite
Issue
Section
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
